,mean_rank,weight
cervix,12.0,3.0
adrenal gland neuroblastoma,17.0,5.0
adrenal gland,23.0,3.0
pancreatic somatostatinoma,33.0,3.0
lung carcinoma,33.0,1.0
right pararenal lymph node,35.0,2.0
neuroblastoma,39.5,52.0
small cell lung carcinoma,42.5,88.0
supraclavicular lymph node,43.0,3.0
thyroid gland squamous cell carcinoma,54.0,3.0
vertebra,54.5,2.0
supra-orbital region,57.0,1.0
medulloblastoma,58.5,8.0
embryonal carcinoma,72.0,1.0
endometrioid stromal sarcoma,73.0,3.0
lung carcinoid tumor,78.5,6.0
prostate carcinoma,82.0,11.0
multiple endocrine neoplasia type 2,95.0,1.0
hereditary thyroid gland medullary carcinoma,95.0,1.0
cervical small cell carcinoma,100.0,1.0
ewing sarcoma,107.0,31.0
gastric small cell neuroendocrine carcinoma,110.0,4.0
testicular embryonal carcinoma,114.0,1.0
mediastinal lymph node,116.0,1.0
ovarian endometrioid adenocarcinoma,117.0,11.0
rhabdomyosarcoma,117.5,4.0
embryonal rhabdomyosarcoma,121.5,6.0
"squamous cell breast carcinoma, acantholytic variant",133.0,3.0
ovarian granulosa cell tumor,138.0,2.0
subserosa of fallopian tube,144.0,1.0
primitive neuroectodermal tumor,148.0,2.0
abdomen,148.0,2.0
salivary gland squamous cell carcinoma,150.0,3.0
right anterior leg,154.0,3.0
right thigh skin,154.5,2.0
high grade ovarian serous adenocarcinoma,157.5,40.0
osteosarcoma,160.0,23.0
large cell lung carcinoma,161.5,32.0
skin nodule,162.0,1.0
adrenal cortex carcinoma,164.0,1.0
brain,164.5,16.0
duodenal adenocarcinoma,166.0,1.0
gastric adenosquamous carcinoma,170.0,2.0
ovarian leiomyosarcoma,173.0,3.0
bone marrow,190.0,65.0
ovarian mixed germ cell tumor,192.0,1.0
oligodendroglioma,193.0,5.0
papillary renal cell carcinoma,195.0,5.0
biphasic synovial sarcoma,197.0,1.0
ovarian carcinoma,197.0,6.0
adenosquamous lung carcinoma,215.0,9.0
rhabdoid tumor of the kidney,219.0,3.0
uterine carcinosarcoma,227.0,2.0
cerebrospinal fluid,232.0,3.0
pleural epithelioid mesothelioma,232.0,18.0
cervical squamous cell carcinoma,235.0,1.0
squamous cell lung carcinoma,236.5,48.0
plasma cell myeloma,241.0,30.0
askin tumor,241.0,2.0
endometrial carcinoma,242.5,8.0
ovarian adenocarcinoma,246.0,5.0
axillary lymph node,249.5,6.0
thyroid gland follicular carcinoma,252.0,10.0
thyroid gland sarcoma,255.0,1.0
myeloid leukemia associated with down syndrome,256.0,1.0
lung giant cell carcinoma,256.0,4.0
peritoneal ascites,260.0,2.0
liposarcoma,260.0,1.0
chronic lymphocytic leukemia,264.5,2.0
cutaneous melanoma,267.5,26.0
groin lymph node,271.0,5.0
not specified,275.0,3.0
primary effusion lymphoma,275.0,3.0
inguinal lymph node,277.0,3.0
ovarian serous cystadenocarcinoma,282.0,4.0
alveolar rhabdomyosarcoma,284.0,9.0
intraperitoneal,285.0,1.0
mucinous gastric adenocarcinoma,285.0,3.0
breast carcinoma,291.0,27.0
anaplastic large cell lymphoma,292.5,8.0
celiac axis lymph node,299.0,2.0
chondrosarcoma,300.0,10.0
thyroid gland undifferentiated (anaplastic) carcinoma,301.0,13.0
melanoma,305.5,94.0
abdominal wall,307.0,2.0
pharyngeal squamous cell carcinoma,308.0,3.0
neurofibromatosis type 1,314.0,1.0
astrocytoma,314.0,19.0
glioblastoma,317.5,84.0
hypopharyngeal squamous cell carcinoma,320.0,5.0
ascites,321.0,103.0
ovarian serous adenocarcinoma,323.0,7.0
pleural effusion,325.5,224.0
hodgkin lymphoma,326.0,11.0
hepatocellular carcinoma,332.0,51.0
poorly differentiated thyroid gland carcinoma,336.0,3.0
undifferentiated pleomorphic sarcoma,338.5,4.0
spleen,343.0,3.0
minimally invasive lung adenocarcinoma,345.0,16.0
lung mucoepidermoid carcinoma,347.0,3.0
endometrial adenosquamous carcinoma,347.5,6.0
lung adenocarcinoma,348.0,145.0
ovarian cystadenocarcinoma,351.5,6.0
squamous papilloma,353.0,1.0
lymph node,355.0,105.0
bronchogenic carcinoma,356.0,2.0
thoracic lymph duct,357.0,1.0
skin squamous cell carcinoma,359.0,1.0
pleural sarcomatoid mesothelioma,362.5,8.0
amelanotic melanoma,363.0,16.0
b acute lymphoblastic leukemia,364.0,5.0
subcutaneous,372.0,7.0
ovarian mucinous adenocarcinoma,374.0,4.0
pelvic wall,379.0,3.0
vaginal melanoma,380.0,1.0
b-cell non-hodgkin lymphoma,385.0,7.0
"invasive ductal carcinoma, not otherwise specified",386.5,30.0
b-cell prolymphocytic leukemia,387.0,2.0
bladder carcinoma,387.0,51.0
ovarian clear cell adenocarcinoma,388.0,13.0
pleural biphasic mesothelioma,389.0,7.0
fibrosarcoma,389.0,5.0
acute myeloid leukemia,391.0,1.0
brachialis muscle,391.0,3.0
n/a,393.0,34.0
pancreatic adenosquamous carcinoma,393.0,5.0
esophageal squamous cell carcinoma,396.0,59.0
uterine corpus leiomyosarcoma,397.0,3.0
omentum,398.0,7.0
mediastinal (thymic) large b-cell lymphoma,400.0,1.0
hepatoblastoma,400.5,4.0
childhood t acute lymphoblastic leukemia,402.0,19.0
renal cell carcinoma,403.0,37.0
gastric carcinoma,403.5,12.0
left leg muscle,406.0,3.0
liver,408.0,32.0
epstein-barr virus-related burkitt lymphoma,409.5,10.0
gallbladder carcinoma,413.0,2.0
endometrial adenocarcinoma,413.5,34.0
"childhood chronic myelogenous leukemia, bcr-abl1 positive",420.5,2.0
gastric adenocarcinoma,425.0,26.0
marek disease,425.0,1.0
uterine corpus sarcoma,428.0,3.0
left supraclavicular lymph node,429.0,4.0
bladder squamous cell carcinoma,429.0,3.0
vulvar leiomyosarcoma,431.0,3.0
hereditary spherocytosis,432.0,1.0
malignant ovarian brenner tumor,434.0,1.0
undifferentiated gallbladder carcinoma,435.0,1.0
pancreatic adenocarcinoma,439.0,39.0
human papillomavirus-related endocervical adenocarcinoma,440.0,4.0
natural killer cell lymphoblastic leukemia/lymphoma,441.0,1.0
vulvar carcinoma,442.0,1.0
pancreatic carcinoma,446.5,12.0
laryngeal squamous cell carcinoma,450.0,12.0
diffuse large b-cell lymphoma germinal center b-cell type,453.5,8.0
skin,455.0,3.0
tonsillar squamous cell carcinoma,456.0,1.0
breast adenocarcinoma,456.0,23.0
hairy cell leukemia,459.0,3.0
epithelioid cell type gastrointestinal stromal tumor,459.0,3.0
myelodysplastic syndrome,460.0,1.0
peripheral blood,462.0,107.0
splenic lymphoma with circulating villous lymphocytes,464.0,1.0
diffuse large b-cell lymphoma,468.5,20.0
mantle cell lymphoma,470.5,6.0
lung,471.0,7.0
familial adenomatous polyposis,474.0,1.0
gastric tubular adenocarcinoma,475.0,11.0
ductal breast carcinoma,480.0,32.0
recurrent bladder carcinoma,481.0,3.0
colon carcinoma,484.0,19.0
gliosarcoma,485.5,6.0
tongue squamous cell carcinoma,489.5,34.0
pancreatic ductal adenocarcinoma,491.0,39.0
clear cell renal cell carcinoma,494.5,18.0
mycosis fungoides and sezary syndrome,496.5,2.0
pericardial effusion,498.0,8.0
ovarian mucinous cystadenocarcinoma,499.0,2.0
"chronic myelogenous leukemia, bcr-abl1 positive",505.0,16.0
non-small cell lung carcinoma,506.5,24.0
adult t acute lymphoblastic leukemia,510.0,5.0
cystic fibrosis,510.5,2.0
intrahepatic cholangiocarcinoma,511.0,6.0
gingival squamous cell carcinoma,511.0,2.0
oral cavity squamous cell carcinoma,511.0,6.0
childhood t lymphoblastic lymphoma,516.5,2.0
ampulla of vater adenocarcinoma,517.5,2.0
cecum adenocarcinoma,523.5,18.0
"endometrial endometrioid adenocarcinoma, variant with squamous differentiation",526.0,2.0
cervical carcinoma,527.0,2.0
buttock,529.0,2.0
bone,529.0,1.0
colon adenocarcinoma,532.0,61.0
childhood b acute lymphoblastic leukemia,535.0,9.0
erythroleukemia,538.0,3.0
obturator lymph node,543.0,3.0
pyriform fossa squamous cell carcinoma,549.0,1.0
b acute lymphoblastic leukemia with t(1;19)(q23;p13.3) e2a-pbx1 (tcf3-pbx1),550.0,4.0
rectosigmoid adenocarcinoma,554.0,3.0
cervical lymph node,554.0,5.0
esophageal adenocarcinoma,560.0,9.0
b acute lymphoblastic leukemia with t(v;11q23) kmt2a rearranged,562.0,3.0
hilar cholangiocarcinoma,565.0,1.0
pleural malignant mesothelioma,572.0,5.0
anaplastic astrocytoma,574.0,5.0
down syndrome,574.5,2.0
childhood acute myeloid leukemia,576.0,2.0
cutaneous t-cell non-hodgkin lymphoma,576.5,2.0
pelvis; innominate bone,577.0,2.0
invasive lobular breast carcinoma,579.0,1.0
subcutaneous; right buttock,583.0,3.0
human papillomavirus-related cervical squamous cell carcinoma,587.5,8.0
barrett adenocarcinoma,588.0,3.0
rectal adenocarcinoma,589.0,11.0
parotid gland mucoepidermoid carcinoma,593.0,1.0
signet ring cell gastric adenocarcinoma,597.0,9.0
burkitt lymphoma,602.5,8.0
peritoneal effusion,605.5,6.0
brca1 syndrome,609.0,1.0
peritoneum,612.0,1.0
lymphoblastic lymphoma,619.0,1.0
right axillary lymph node,621.0,1.0
small intestine,622.0,1.0
brca2 syndrome,626.0,1.0
papillary lung adenocarcinoma,631.0,3.0
head and neck squamous cell carcinoma,640.0,9.0
paragastric lymph node,650.5,2.0
buccal mucosa squamous cell carcinoma,653.0,2.0
adult acute monocytic leukemia,691.0,5.0
diffuse large b-cell lymphoma activated b-cell type,700.0,1.0
follicular lymphoma,721.0,2.0
adult b acute lymphoblastic leukemia,726.0,3.0
vulvar squamous cell carcinoma,746.0,3.0
benign prostatic hyperplasia,749.0,1.0
adult acute myeloid leukemia,755.0,22.0
gastric choriocarcinoma,756.0,1.0
cholangiocarcinoma,758.0,2.0
childhood acute myeloid leukemia with maturation,760.0,1.0
mandible,769.0,1.0
oral dysplasia,782.0,1.0
gestational choriocarcinoma,785.5,2.0
thigh skin,803.0,1.0
lymphoma,852.0,1.0
epithelioid sarcoma,857.0,1.0
childhood acute monocytic leukemia,865.0,2.0
acute promyelocytic leukemia with t(15;17)(q22;q12) pml-rara,866.0,1.0
left cervical lymph node,876.0,1.0
thyroid gland papillary carcinoma,876.0,1.0
vulvar melanoma,916.0,1.0
"chronic eosinophilic leukemia, not otherwise specified",938.0,1.0
floor of mouth squamous cell carcinoma,944.0,1.0
gastric fundus carcinoma,948.0,1.0
ovary,957.0,1.0
squamous cell carcinoma,958.0,1.0
acute myelomonocytic leukemia,979.0,1.0
meninges,979.0,1.0
